Storage of genetic
data using blockchain

LifeBank Chain is a leading clinic-stage biotechnology company
seeking to improve lives through the curative potential of gene
and cell therapy.

Storage of genetic
data using blockchain

LifeBank Chain is a leading clinic-stage biotechnology company
seeking to improve lives through the curative potential of gene
and cell therapy.

Discover


Lifebank Chain Focuses on the research, development of genetics, cytology,
expands the innovative applications of genetics and cytology in
clinical treatment through cutting-edge technology.

 First


You solve gene and cell
data security issues.

 Second


You solve data access
and data mining
performance issues. 

 Third


You solve gene and
cell data rational use
issues. 

LBC Milestones

2022


  • Development and integration of smart contract technology
  • Recruitment of potential gene research laboratories and stem cell science research teams

2023


  • Testing and trial operation of LBC blockchain technology
  • Testing and demonstration of the LBC Rollout Program V1.0

2024


  • Q1: Announcement of the first LBC laboratory site selection and franchising expansion plan
  • Q2: Hiring a Big Four accounting firm to conduct annual audits in accordance with U.S. accounting standards and issue audit reports
  • Q3: Announcement of clinical development and research strategies in the fields of genetics and stem cells
  • Q4:
    • Deployment of offline nodes in Asia and Southeast Asia
    • Construction of laboratories and offline product experience warehouses

2025


  • Q1:
    • Start of LBC Application 1.0 development
    • Establishment of a technical rebranding plan, including:
      • Optimization of platform architecture
      • Enhancement of user experience (UX) and system performance
      • Updates to data security and privacy technologies
  • Q2:
    • Execution of rebranding initiatives:
      • Implementation of a new blockchain infrastructure integrated with existing systems
      • Upgrades to the platform interface for users
      • Utilization of cloud technologies for global user data management
  • Q3: Launch of LBC Application 1.1: Integration of doctors and users from South Korea, Japan, Singapore, and China into the LBC platform
  • Q4:
    • Launch of LBC Application 2.0: Integration of professionals, patients, and gene and laboratory researchers from Europe and North America
    • Start of online sales of genetic and stem cell products

2026


  • Q1: Launch of LBC Application 3.0: Providing a full-featured platform for professionals and patients
  • Q2: Expansion of the global user base and addition of personalized service features

Management Team




The team of researchers and 

genome experts supporting the program
is based in Singapore, 

Canada and China, and include two Nobel
prize winners.

This makes LBC the first of its kind
to be supported by Nobel Prize laureates.




Advisor

Randy Schekman 






Advisor

Sabeeha Merchant




Our Investment

Our Research and development partners


Lifebank Chain is constantly looking for partners and research
collaborators. Contacts us for more information.



Overview


Cell therapy


Genetic therapy


Lifebank


LBC heath

Career


 GENE & CELL MEDICINE LTD


 5119 KILLDEER DR PUEBLO, CO 81008